ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,696
Screening encounters
3,005
Diagnostic referrals
587
Outstanding pathways
233

Screening pathway

  1. Screening3,005Encounters
  2. Positive finding1,027Documented findings
  3. Referral587Diagnostic referrals
  4. Follow-up661Diagnostic visits
  5. Outcome354Resolved pathways

Stage totals use different units. Pending pathways: 233. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3702 · EXP-3702Synthetic · Site A

Full participant history through 2026-04-26, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2027-02-13

Referral-time risk

No matching referral was available at this observation date.

Screened participants

2696 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3286 · Expanded synthetic participant 3286Site A — Urban Referral Hub
EXP-3288 · Expanded synthetic participant 3288Site B — Peri-Urban Access Programme
EXP-3295 · Expanded synthetic participant 3295Site B — Peri-Urban Access Programme
EXP-3297 · Expanded synthetic participant 3297Site A — Urban Referral Hub
EXP-3301 · Expanded synthetic participant 3301Site A — Urban Referral Hub
EXP-3302 · Expanded synthetic participant 3302Site E — Resource-Constrained Navigation Programme
EXP-3303 · Expanded synthetic participant 3303Site D — Community Engagement Programme
EXP-3304 · Expanded synthetic participant 3304Site A — Urban Referral Hub
EXP-3306 · Expanded synthetic participant 3306Site B — Peri-Urban Access Programme
EXP-3308 · Expanded synthetic participant 3308Site D — Community Engagement Programme
EXP-3310 · Expanded synthetic participant 3310Site C — Rural Outreach Programme
EXP-3311 · Expanded synthetic participant 3311Site A — Urban Referral Hub
EXP-3312 · Expanded synthetic participant 3312Site D — Community Engagement Programme
EXP-3313 · Expanded synthetic participant 3313Site C — Rural Outreach Programme
EXP-3317 · Expanded synthetic participant 3317Site C — Rural Outreach Programme
EXP-3319 · Expanded synthetic participant 3319Site C — Rural Outreach Programme
EXP-3322 · Expanded synthetic participant 3322Site A — Urban Referral Hub
EXP-3323 · Expanded synthetic participant 3323Site D — Community Engagement Programme
EXP-3327 · Expanded synthetic participant 3327Site D — Community Engagement Programme
EXP-3332 · Expanded synthetic participant 3332Site C — Rural Outreach Programme
EXP-3335 · Expanded synthetic participant 3335Site C — Rural Outreach Programme
EXP-3337 · Expanded synthetic participant 3337Site B — Peri-Urban Access Programme
EXP-3338 · Expanded synthetic participant 3338Site C — Rural Outreach Programme
EXP-3341 · Expanded synthetic participant 3341Site A — Urban Referral Hub
EXP-3342 · Expanded synthetic participant 3342Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1238
HPV DNA
1320
Cytology
447

Navigation activity

Barrier documented
495
Contact attempt
857
Navigation intervention
213
Diagnostic booking
719
Diagnostic visit
661

Documented barriers

Contact difficulty
161
Transport difficulty
151
Appointment coordination
183

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.